Bioimpedance Analyzers Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Bioimpedance Analyzers Market

Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 7973 Jul, 2023, by marketsandmarkets.com

The global bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals and fitness clubs, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market.

Attractive Opportunities in the Bioimpedance Analyzers Market

Bioimpedance Analyzers Market

To know about the assumptions considered for the study, Request for Free Sample Report

Bioimpedance Analyzers Market

Bioimpedance Analyzers Market Dynamics

DRIVER: Increasing prevalence of lifestyle diseases

The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation.

According to the World Obesity Atlas 2023, over 4 billion people may be affected by 2035, compared with over 2.6 billion in 2020. Thus, there is an increase from 38% of the world’s population in 2020 to over 50% by 2035. The prevalence of obesity (BMI ≥30kg/m²) alone is anticipated to rise from 14% to 24% of the population over the same period, affecting nearly 2 billion adults, children, and adolescents by 2035.

RESTRAINT: High cost of analyzers

The smaller healthcare facilities, clinics, and resource-constrained regions will get limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing. For some healthcare facilities, fitness centers, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000.

OPPORTUNITY: Integration with wearable devices

Wearable devices, such as fitness trackers or smartwatches, to monitor body composition and hydration status could be integrated with bioimpedance analyzers. This integration will allow for real-time data collection and analysis, which will enable individuals to track their health parameters throughout the day and make informed decisions about their lifestyle and behavior.

Although bioimpedance monitoring is not a new concept, wearable bioimpedance monitoring for chronic conditions is a relatively new field [Source: Journal of Medical Internet Research (JMIR)].

CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers

Although valuable information about body composition and hydration status can be obtained with bioimpedance analyzers, their accuracy may vary depending on age, gender, body type, and hydration level. They may not be as accurate as gold standard methods like DEXA or hydrostatic weighing in some cases. The number represents an estimate of the total body fat percentage, even though one gets an accurate reading on a bioimpedance scale. Most of the scales also cannot tell where fat is located in the body. Even though many factors can affect reading accuracy, a regular BIA scale can show changes in body fat over time. However, the obtained number may not be accurate but can still track changes to the body composition. This limitation can deter healthcare professionals and researchers who require exact measurements.

BIOIMPEDANCE ANALYZERS ECOSYSTEM

Prominent companies in this market include well-established, financially stable manufacturers of bioimpedance analyzers. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks. Prominent companies in this market include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), and Seca GmbH & Co. KG (Germany).

Bioimpedance Analyzers Market Ecosystem

In 2022, multi-frequency bioimpedance analyzers segment to observe the highest growth rate of the bioimpedance analyzers industry, by product.

Based on product, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like advanced tissue differentiation and integration with other technologies.

“In 2022, segmental body measurement segment to dominate the bioimpedance analyzers industry, by application.

Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to tracking changes in specific body segments by athletes and monitoring the effectiveness of the training programs.

In 2022, North America to dominate in bioimpedance analyzers industry.

The global bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the high promotion of healthy lifestyles, sedentary work life, and large population consuming junk food.

Bioimpedance Analyzers Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The bioimpedance analyzers market is dominated by players such as OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), and Seca GmbH & Co. KG (Germany)

Scope of the Bioimpedance Analyzers Industry

Report Metric 

Details 

Market Revenue in 2023

$564 million

Projected Revenue by 2028

$927 million

Revenue Rate

Poised to Grow at a CAGR of 10.4%

Market Driver

Increasing prevalence of lifestyle diseases

Market Opportunity

Integration with wearable devices

This research report categorizes the bioimpedance analyzers market to forecast revenue and analyze trends in each of the following submarkets:

By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Product
  • Multi-frequency Bioimpedance Analyzers
  • Single-frequency Bioimpedance Analyzers
  • Dual-frequency Bioimpedance Analyzers

By Modality
  • Wired Bioimpedance Analyzers
  • Wireless Bioimpedance Analyzers

By Usage Type
  • Consumer-grade Bioimpedance Analyzers
  • Professional-grade Bioimpedance Analyzers

By Application
  • Whole-body Measurement
  • Segmental Body Measurement

By End User
  • Hospitals & Clinics
  • Fitness Clubs & Wellness Centers
  • Home Users
  • Other End Users

Recent Developments of Bioimpedance Analyzers Industry

  • In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology.
  • In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer.
  • In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 23)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 LIMITATIONS 
 
2 RESEARCH METHODOLOGY (Page No. - 27)
    2.1 RESEARCH DATA 
          FIGURE 1 BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    TABLE 2 KEY DATA FROM PRIMARY SOURCES
                    2.1.2.1 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.2.1.1 Growth forecast
                                FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                                FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
    FIGURE 10 BIOIMPEDANCE ANALYZERS INDUSTRY, BY MODALITY, 2023 VS. 2028 (USD BILLION)
    FIGURE 11 MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION)
    FIGURE 12 MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
    FIGURE 14 MARKET: GEOGRAPHICAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 44)
    4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW 
          FIGURE 15 INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS INDUSTRY
    4.2 ASIA PACIFIC: MARKET, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 2022
    4.3 REGIONAL GROWTH OPPORTUNITIES IN MARKET 
          FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET: REGIONAL MIX 
          FIGURE 18 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 BIOIMPEDANCE ANALYZERS MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of lifestyle diseases
                    5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
                    5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
           5.2.2 RESTRAINTS
                    5.2.2.1 Presence of alternative methods
                    5.2.2.2 High cost of analyzers
                                TABLE 3 BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets across Asia Pacific and Latin America
                    5.2.3.2 Integration with wearable devices
           5.2.4 CHALLENGES
                    5.2.4.1 Inconsistency in accuracy of different bioimpedance analyzers
    5.3 SUPPLY CHAIN ANALYSIS 
          FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 22 BIOIMPEDANCE ANALYZERS INDUSTRY: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 23 MARKET: ECOSYSTEM ANALYSIS
           5.5.1 ROLE IN ECOSYSTEM
                    FIGURE 24 MARKET ECOSYSTEM: KEY PLAYERS
    5.6 REGULATORY LANDSCAPE 
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                                TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
                    5.6.1.2 Canada
                                TABLE 5 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.6.2 EUROPE
           5.6.3 ASIA PACIFIC
                    5.6.3.1 Japan
                                TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.6.3.2 China
                                TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.6.3.3 India
                                TABLE 8 REGULATORY AUTHORITIES
    5.7 PORTER’S FIVE FORCES ANALYSIS 
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 INTENSITY OF COMPETITIVE RIVALRY
           5.7.5 THREAT OF SUBSTITUTES
    5.8 PATENT ANALYSIS 
          FIGURE 25 PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013–NOVEMBER 2022)
    5.9 TRADE ANALYSIS 
          TABLE 9 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
          TABLE 10 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
    5.10 TECHNOLOGY ANALYSIS 
    5.11 PRICING ANALYSIS 
           TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
    5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
                     FIGURE 26 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS
 
6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT (Page No. - 68)
    6.1 INTRODUCTION 
          TABLE 12 BIOIMPEDANCE ANALYZERS INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 
           6.2.1 ACCURACY AND PRECISION TO DRIVE MARKET
                    TABLE 13 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
                    TABLE 14 MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 
           6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE MARKET
                    TABLE 15 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
                    TABLE 16 MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 
           6.4.1 SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH
                    TABLE 17 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
                    TABLE 18 MARKET, BY REGION, 2021–2028 (USD MILLION)
 
7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (Page No. - 73)
    7.1 INTRODUCTION 
          TABLE 19 BIOIMPEDANCE ANALYZERS INDUSTRY, BY MODALITY, 2021–2028 (USD MILLION)
    7.2 WIRELESS BIOIMPEDANCE ANALYZERS 
           7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE
                    TABLE 20 MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 WIRED BIOIMPEDANCE ANALYZERS 
           7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE DEMAND
                    TABLE 21 MARKET, BY REGION, 2021–2028 (USD MILLION)
 
8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE (Page No. - 76)
    8.1 INTRODUCTION 
          TABLE 22 BIOIMPEDANCE ANALYZERS INDUSTRY, BY USAGE TYPE, 2021–2028 (USD MILLION)
    8.2 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS 
           8.2.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET
                    TABLE 23 MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.3 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS 
           8.3.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET
                    TABLE 24 MARKET, BY REGION, 2021–2028 (USD MILLION)
 
9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (Page No. - 80)
    9.1 INTRODUCTION 
          TABLE 25 BIOIMPEDANCE ANALYZERS INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 SEGMENTAL BODY MEASUREMENT 
           9.2.1 RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION
                    TABLE 26 MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
    9.3 WHOLE-BODY MEASUREMENT 
           9.3.1 GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET
                    TABLE 27 MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
 
10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER (Page No. - 83)
     10.1 INTRODUCTION 
             TABLE 28 BIOIMPEDANCE ANALYZERS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.2 FITNESS CLUBS & WELLNESS CENTERS 
             10.2.1 FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET
                       FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012–2022
                       TABLE 29 MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021–2028 (USD MILLION)
     10.3 HOME USERS 
             10.3.1 AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION
                       TABLE 30 MARKET FOR HOME USERS, BY REGION, 2021–2028 (USD MILLION)
     10.4 HOSPITALS & CLINICS 
             10.4.1 NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION
                       TABLE 31 MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
     10.5 OTHER END USERS 
             TABLE 32 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
 
11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION (Page No. - 89)
     11.1 INTRODUCTION 
             TABLE 33 BIOIMPEDANCE ANALYZERS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
             TABLE 34 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 35 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 36 NORTH AMERICA: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 37 NORTH AMERICA: MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
             TABLE 38 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 39 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 RECESSION IMPACT
             11.2.2 US
                        11.2.2.1 Rising obesity rate and interest in health clubs & fitness centers to drive market
                                     TABLE 40 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 41 US: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 42 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 43 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 High prevalence of obesity in Canada to support market growth
                                     TABLE 44 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 45 CANADA: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 46 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 47 CANADA: BIOIMPEDANCE ANALYZERS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     11.3 EUROPE 
             TABLE 48 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 49 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 50 EUROPE: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 51 EUROPE: MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
             TABLE 52 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 53 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.1 RECESSION IMPACT
             11.3.2 GERMANY
                        11.3.2.1 Germany to hold largest market share in Europe
                                     TABLE 54 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 55 GERMANY: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 56 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 57 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Rising incidence of kidney disorders to drive market
                                     TABLE 58 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 59 UK: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 60 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 61 UK: BIOIMPEDANCE ANALYZERS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Increasing obese population and rising prevalence of metabolic disorders to drive market
                                     TABLE 62 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 63 FRANCE: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 64 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 65 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.5 REST OF EUROPE
                        TABLE 66 REST OF EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 67 REST OF EUROPE: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 68 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 69 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 RECESSION IMPACT
                        FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
                        TABLE 70 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 71 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 72 ASIA PACIFIC: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 73 ASIA PACIFIC: MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 74 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 75 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Government initiatives to drive market
                                     TABLE 76 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 77 JAPAN: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 78 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 79 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 China to register highest CAGR in APAC market
                                     TABLE 80 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 81 CHINA: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 82 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 83 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 AUSTRALIA
                        11.4.4.1 High prevalence of obesity to drive market
                                     TABLE 84 AUSTRALIA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 85 AUSTRALIA: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 86 AUSTRALIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 87 AUSTRALIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 PHILIPPINES
                        11.4.5.1 Favorable government initiatives to support market growth
                                     TABLE 88 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 89 PHILIPPINES: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 90 PHILIPPINES: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 91 PHILIPPINES: BIOIMPEDANCE ANALYZERS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.4.6 TAIWAN
                        11.4.6.1 Increasing incidence of lifestyle diseases to drive market
                                     TABLE 92 TAIWAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                     TABLE 93 TAIWAN: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                     TABLE 94 TAIWAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                     TABLE 95 TAIWAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                        TABLE 96 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 97 REST OF ASIA PACIFIC: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 98 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 99 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 RECESSION IMPACT
                        TABLE 100 REST OF THE WORLD: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 101 REST OF THE WORLD: MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 102 REST OF THE WORLD: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 103 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 126)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
     12.3 MARKET SHARE ANALYSIS 
             TABLE 105 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
     12.4 COMPANY EVALUATION MATRIX (2022) 
             12.4.1 STARS
             12.4.2 EMERGING LEADERS
             12.4.3 PERVASIVE PLAYERS
             12.4.4 PARTICIPANTS
                        FIGURE 30 BIOIMPEDANCE ANALYZERS INDUSTRY: COMPANY EVALUATION MATRIX, 2022
     12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 
             12.5.1 PROGRESSIVE COMPANIES
             12.5.2 STARTING BLOCKS
             12.5.3 RESPONSIVE COMPANIES
             12.5.4 DYNAMIC COMPANIES
                        FIGURE 31 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     12.6 COMPETITIVE BENCHMARKING 
             TABLE 106 MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 107 PRODUCT FOOTPRINT ANALYSIS
             TABLE 108 REGIONAL FOOTPRINT ANALYSIS
             TABLE 109 MARKET: DETAILED LIST OF KEY START-UPS/SMES
     12.7 COMPETITIVE SCENARIO 
             12.7.1 PRODUCT LAUNCHES
                        TABLE 110 PRODUCT LAUNCHES, 2020–2023
             12.7.2 DEALS
                        TABLE 111 DEALS, 2020–2023
             12.7.3 OTHER DEVELOPMENTS
                        TABLE 112 OTHER DEVELOPMENTS, 2020–2023
 
13 COMPANY PROFILES (Page No. - 137)
     13.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             13.1.1 OMRON CORPORATION
                        TABLE 113 OMRON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 32 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.2 TANITA CORPORATION
                        TABLE 114 TANITA CORPORATION: BUSINESS OVERVIEW
             13.1.3 INBODY CO., LTD.
                        TABLE 115 INBODY CO., LTD.: BUSINESS OVERVIEW
                        TABLE 116 INBODY CO., LTD.: DEALS
                        TABLE 117 INBODY CO., LTD.: OTHER DEVELOPMENTS
             13.1.4 RJL SYSTEMS, INC.
                        TABLE 118 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
             13.1.5 SECA GMBH & CO. KG
                        TABLE 119 SECA GMBH & CO. KG: BUSINESS OVERVIEW
             13.1.6 EVOLT 360
                        TABLE 120 EVOLT 360: BUSINESS OVERVIEW
             13.1.7 SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL)
                        TABLE 121 SELVAS HEALTHCARE: BUSINESS OVERVIEW
             13.1.8 FOOK TIN TECHNOLOGIES LTD.
                        TABLE 122 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
             13.1.9 BODYSTAT LTD.
                        TABLE 123 BODYSTAT LTD.: BUSINESS OVERVIEW
                        TABLE 124 BODYSTAT LTD.: PRODUCT LAUNCHES
             13.1.10 CHARDER ELECTRONIC CO., LTD.
                        TABLE 125 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
             13.1.11 MALTRON INTERNATIONAL
                        TABLE 126 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     13.2 OTHER PLAYERS 
             13.2.1 BIOTEKNA
             13.2.2 BIODYNAMICS CORPORATION
             13.2.3 AKERN
             13.2.4 WITHINGS
             13.2.5 XIAOMI
             13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
             13.2.7 LUMSAIL INDUSTRIAL INC.
             13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
             13.2.9 BIOPARHOM
             13.2.10 MICROLIFE
             13.2.11 SONKA MEDICAL TECHNOLOGY CO., LIMITED
             13.2.12 NUMED S.A.R.L.
             13.2.13 WUNDER SA.BI. SRL.
             13.2.14 SHENZHEN YOLANDA TECHNOLOGY CO., LTD
             13.2.15 BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.)
 
14 APPENDIX (Page No. - 163)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the bioimpedance analyzers market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the bioimpedance analyzers market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the bioimpedance analyzers market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, clinics, fitness centers, home users, and academic & research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants

Bioimpedance Analyzers Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various bioimpedance analyzers were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value bioimpedance analyzers market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of bioimpedance analyzers market at the regional and country-level 
  • Relative adoption pattern of each bioimpedance analyzers market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Bioimpedance analyzers Market Size: Top Down Approach

Bioimpedance Analyzers Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Bioimpedance analyzers Market Size: Bottom-Up Approach

Bioimpedance Analyzers Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Bioimpedance analyzers industry.

Market Definition

Bioimpedance analysis (also known as bioelectric impedance analysis) is a method of assessing body composition, which measures body fat in relation to lean body mass. It determines the resistance to the flow of electric current as it passes through the body. Bioimpedance analyzers are medical devices that are used to measure the impedance of biological tissues. The opposition that tissue or substance presents to the flow of an alternating electrical current is known as impedance.

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • Nutritionist/Dietitian/Physiotherapist/Fitness Trainer

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall bioimpedance analyzers market
  • To forecast the size of the bioimpedance analyzers market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
  • To profile key players in the bioimpedance analyzers market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the bioimpedance analyzers market.
  • To benchmark players within the bioimpedance analyzers market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Bioimpedance analyzers market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Bioimpedance Analyzers Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 7973
Published ON
Jul, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bioimpedance Analyzers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback